DV Biomed Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	7.74	89.08	162.91	281.26	304.58
Depreciation & Amortization	35.42	18.3	23.05	180.16	176.26
Other Amortization	-	1.19	1.78	3.41	-7.51
Loss (Gain) From Sale of Assets	0.42	-5.35	0.02	2.01	4.73
Loss (Gain) From Sale of Investments	-1.14	-1.79	-11.45	-5.47	-0.3
Loss (Gain) on Equity Investments	-	-	-	26.15	27.97
Provision & Write-off of Bad Debts	0.05	-1.29	1.11	-0.6	-1.79
Other Operating Activities	-2.4	10.46	-81.32	-3.66	15.26
Change in Accounts Receivable	3.18	48.73	-45.4	53.24	-33.76
Change in Inventory	-25.11	-3.12	10.27	-1.83	-20.44
Change in Accounts Payable	3.41	4.85	7.62	-5.12	19.19
Change in Unearned Revenue	7.46	2.01	-2.41	0.94	19.77
Change in Other Net Operating Assets	28.84	-43.2	-5.92	-0.17	18.64
Operating Cash Flow	57.5	119.04	69.61	522.58	522.59
Operating Cash Flow Growth	-51.70%	71.00%	-86.68%	-0.00%	12.85%
Capital Expenditures	-28.15	-1.52	-2.52	-120.76	-62.22
Sale of Property, Plant & Equipment	0.22	74.48	-	3.37	-
Divestitures	-	1.73	-9.01	-	-
Sale (Purchase) of Intangibles	-12.25	-4.7	-	-1.46	-7.09
Investment in Securities	-49.42	-117.89	79.44	-77.83	-38.26
Other Investing Activities	-3.55	-0.31	2.72	-1.32	2.8
Investing Cash Flow	-86.13	-30.88	70.63	-198.01	-104.77
Short-Term Debt Issued	-	-	-	-	30
Total Debt Issued	-	-	-	-	30
Short-Term Debt Repaid	-	-	-	-	-30
Long-Term Debt Repaid	-21.57	-32.4	-10.35	-77.2	-67.92
Total Debt Repaid	-21.57	-32.4	-10.35	-77.2	-97.92
Net Debt Issued (Repaid)	-21.57	-32.4	-10.35	-77.2	-67.92
Repurchase of Common Stock	-	-	-	-42.16	-
Common Dividends Paid	-37.14	-80.43	-298.96	-306.65	-325.94
Other Financing Activities	0.5	9.52	0.11	-	-
Financing Cash Flow	-58.21	-103.3	-309.2	-426.01	-393.86
Foreign Exchange Rate Adjustments	-13.18	2.88	4.22	0.64	0.05
Net Cash Flow	-100.02	-12.27	-164.75	-100.79	24.01
Free Cash Flow	29.35	117.52	67.09	401.83	460.37
Free Cash Flow Growth	-75.02%	75.17%	-83.30%	-12.72%	24.50%
Free Cash Flow Margin	3.70%	20.49%	10.84%	21.53%	25.20%
Free Cash Flow Per Share	-	4.82	2.75	16.43	18.68
Cash Interest Paid	-	1.68	0.16	5.29	4.45
Cash Income Tax Paid	-	18.25	77.32	84.02	73.45
Levered Free Cash Flow	33.82	68.79	78.2	329.69	374.48
Unlevered Free Cash Flow	34.75	69.84	78.3	332.95	377.26
Change in Working Capital	17.77	9.27	-35.84	47.06	3.39

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.